Non-Mainstream Pooled Investment („NMPI“) Status

HBM Healthcare Investments currently conducts its affairs so that securities issued by the company can be recommended by financial advisers to ordinary retail investors in accordance with the FCA’s (Financial Conduct Authority, London) rules in relation to non-mainstream pooled investment products (NMPIs) and intends to continue to do so for the foreseeable future.

The company’s securities are thus excluded from the FCA’s restrictions which apply to non-mainstream investment products because of the nature and characteristics of the company’s underlying investments (being wholly or predominantly private equity investments in shares or debt instruments).



HBM Healthcare Investments Quartalsbericht Juni 2017

Unternehmens- präsentation



SIX Swiss Exchange Ticker


per 15. Oktober 2017 CHF
NAV pro Aktie 154.89
Nettovermögen Mio. 1'083

© HBM Healthcare Investments AG